Imagine battling a life-threatening illness only to face a second fight against your own insurance provider—denying you the financial lifeline you desperately need. That's the harsh reality for many Malaysians navigating private health insurance, and it's sparking urgent calls for change.
In Kuala Lumpur, two opposition Members of Parliament (MPs), both practicing doctors, have voiced strong appeals for stricter oversight of Malaysia's private health insurance sector. They emphasize the need for regulated timelines in handling claims to eliminate unnecessary delays and to outlaw the rejection of claims solely due to pre-existing health conditions that aren't directly related to the current illness.
Dr. Halimah Ali, the MP for Kapar and a member of Parliament's Public Accounts Committee (PAC), along with Dr. Ahmad Yunus Hairi, the MP for Kuala Langat, are pushing the government to cap the duration insurers can spend probing a claim and to restrict the circumstances under which they can request old medical records. This comes as a response to widespread frustrations in the industry.
Meanwhile, Sim Tze Tzin, the MP for Bayan Baru from Pakatan Harapan and also a PAC member, stresses the importance of utilizing current complaint pathways and cautions against the government imposing overly detailed control, or what she calls 'micromanagement,' on the sector.
But here's where it gets controversial: Is it the insurers' right to scrutinize every detail, or should patient needs take precedence over bureaucratic hurdles? A recent report by CodeBlue highlighted the distressing story of 57-year-old Ramu Krishnan Sinnamuthry, who is battling stage four tongue cancer. Despite submitting three claims related to his cancer to Allianz Life Insurance Malaysia Berhad, all remain unpaid more than four months after a CT scan in July. The insurer has put everything on hold for an inquiry into a hypertension episode from 2024 that Ramu never claimed for, demanding medical records going back to 2017. In the meantime, Ramu has personally covered around RM69,000 for his diagnostic tests and cancer treatments.
Dr. Halimah, who is aligned with Perikatan Nasional (PN) and the PAS party, points out that Ramu's experience mirrors a pattern of problems: drawn-out waits due to probes into past health issues and demands for extensive paperwork spanning years, even as patients require immediate financial aid. She describes these tactics as placing an unfair strain on those who are gravely ill. To illustrate, she references mySalam, a government takaful scheme run by the Ministry of Finance through Great Eastern Takaful Berhad (GETB), which offers coverage for critical illnesses and hospitalization costs. Alarmingly, mySalam has a payout rate of just 54%, as reported in a recent CodeBlue article, highlighting systemic inefficiencies that need fixing.
And this is the part most people miss: Why should a government-backed scheme fall short when private options perform better? Dr. Halimah insists that insurers shouldn't be permitted to drag out decisions by endlessly requesting more paperwork. Once essential documents are submitted, she argues, companies must legally commit to approving or denying the claim within a set timeframe. Additionally, she advocates for boundaries on how far back they can ask for records—say, limiting it to a reasonable period like a few years rather than stretching to six or seven, particularly for unrelated conditions never previously claimed. Transparency, responsibility, and a fair method to appeal decisions, she says, should be at the heart of any reforms.
Regarding the government's upcoming basic medical and health insurance/takaful (MHIT) initiative, Dr. Halimah urges authorities to embed robust safeguards if private insurers are involved. This would include banning open-ended claim deferrals, defining precise reasons for investigations, capping documentation requests, automatically approving claims for verified critical conditions, and imposing fines on insurers that unjustifiably postpone, reject, or complicate valid claims. Her goal? To prevent MHIT from echoing mySalam's flaws, where overwhelming paperwork and a low approval rate have left countless families in distress during crises. "Insurance should protect people, not exhaust them," she passionately declares.
In a parliamentary session on November 27, Dr. Halimah echoed these concerns, focusing on the hardships faced by low-income Malaysians with the B40 group. She questioned why mySalam, designed to shield this demographic, achieves only a 54% approval rate, lagging far behind the private sector's typical 90% success. Since 2019, over 921,000 mySalam claims have been turned down. She drew a comparison to Skim Perubatan Madani (SPM), where patients simply present their MyKad for access, without the bureaucracy. Unlike mySalam, which relies on a private insurer and takaful operator (ITO), SPM is managed by ProtectHealth Corporation Sdn Bhd, a Ministry of Health-owned entity.
The Deputy Finance Minister, Lim Hui Ying, responded in Parliament by stating that mySalam claims follow established procedures handled by GETB, without addressing the deeper issues.
Dr. Ahmad Yunus Hairi, also from PN and PAS, emphasizes that insurers should cease using pre-existing conditions as a universal excuse to stall or refuse claims, particularly when those conditions don't connect medically to the patient's current diagnosis. He suggests ITOs (Insurers and Takaful Operators) consider Malaysia's health trends when setting policy terms.
Given the rising prevalence of non-communicable diseases (NCDs) annually, ITOs can't just dismiss coverage, he argues, especially if prior conditions are unrelated to the present treatments. For context, the Malaysia National Cancer Registry Report from 2017-2021 reveals a troubling rise in late-stage cancer diagnoses, with 65% of cases detected at stages three or four. Meanwhile, the National Health and Morbidity Survey 2023 indicates over two million adults have at least three NCDs like diabetes, hypertension, high cholesterol, or obesity, and around 500,000 suffer from all four, often unaware of their conditions.
But here's the controversial angle: Should insurers have the power to second-guess doctors, or is that overstepping into clinical territory that could harm patients? Dr. Ahmad Yunus calls for a total ban on denying coverage for medically prescribed interventions—such as surgeries, medications, or therapies—unless solid proof exists that the treatment isn't needed. He stresses the necessity for uniform, standardized guidelines to ensure ITOs and third-party administrators (TPAs) operate with clarity and predictability. Without these, each entity follows its own rules, leading to inconsistent outcomes.
These guidelines should outline fixed schedules for each claim phase: from initial submission and guarantee letter processing to the final verdict. Insurers, he adds, must not meddle in clinical judgments. "The separation of powers between clinical decisions and financing decisions is critical to ensure that patient safety and health are not compromised by financial considerations alone," he explains. This is vital in today's complex medical landscape, where claim handlers need a strong grasp of medical basics, terms, and treatment logic.
Currently, many insurance agents and staff lack formal healthcare training, resulting in illogical choices that burden patients. For example, ITOs and TPAs rarely employ specialist doctors; PMCare Sdn Bhd, Malaysia's oldest TPA, boasts just 15 physicians—far more than typical insurers with only two or three—but none are specialists, as noted in a CodeBlue piece.
To resolve disputes swiftly and justly, Dr. Yunus proposes establishing a dedicated health insurance tribunal, comprised of lawyers, doctors, and insurance experts who understand both medical and contractual nuances. Tribunal rulings should be binding and enforceable right away, with authority to penalize insurers for deliberate delays or denials.
For the new MHIT scheme, he insists underwriters must accept all applicants, irrespective of health, age, or prior conditions. Plus, there should be firm deadlines and monitoring of premium hikes, with an impartial board reviewing denials or appeals. If claims outstrip government funding, any rate increases must be vetted by the Ministry, the Parliamentary Special Select Committee (PSSC), or the National Audit Department.
In contrast, Sim Tze Tzin, from PKR, chose not to address Ramu's specific case but acknowledged that such challenges arise because many policyholders are unaware of available resources when claims hit snags. As a PAC member, she notes that people often depend solely on their agents, overlooking official channels for grievances.
She outlines the redress process: First, contact the insurer directly; if unresolved, escalate to Bank Negara; and if still dissatisfied, turn to the Financial Markets Ombudsman Services (FMOS). "I hope that more policyholders will understand their rights. They still have rights. The government still has a mechanism to help them. They are not alone," she encourages.
When queried about enforcing strict claim processing deadlines, Sim believes it's not the government's place to impose day limits on insurers. "They must have that SOP [Standard Operating Procedure]. How can the government go in and say how many days? I think that’s not the way to address this issue. We don’t micromanage," she responds. Instead, the focus should be on maintaining effective complaint systems, not dictating internal insurer operations. "We cannot regulate everything. The complaint mechanism is there."
Regarding MHIT, it's premature to comment, as the product is still in development. "Let’s wait for them to roll out. Be patient. Let them do their job. We don’t want to rush things and then they come out halfway and then we have a bigger problem."
Now, it's your turn: Do you think the government should step in with more regulations to protect patients, or would that stifle innovation in the insurance industry? Is denying claims based on unrelated pre-existing conditions ever justified, or is it just a way for companies to avoid payouts? Share your thoughts in the comments—do you agree with the MPs' demands, or see a counterpoint we're missing? Let's discuss!
